These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18323523)

  • 1. Beneficial effect of the central nervous system beta-adrenoceptor blockade on the failing heart.
    Gourine A; Bondar SI; Spyer KM; Gourine AV
    Circ Res; 2008 Mar; 102(6):633-6. PubMed ID: 18323523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart.
    Maczewski M; Mackiewicz U
    Cardiovasc Res; 2008 Jul; 79(1):42-51. PubMed ID: 18310678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotection, attenuated systemic inflammation, and survival benefit of beta1-adrenoceptor blockade in severe sepsis in rats.
    Ackland GL; Yao ST; Rudiger A; Dyson A; Stidwill R; Poputnikov D; Singer M; Gourine AV
    Crit Care Med; 2010 Feb; 38(2):388-94. PubMed ID: 19829100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in beta-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system.
    Sethi R; Shao Q; Ren B; Saini HK; Takeda N; Dhalla NS
    Mol Cell Biochem; 2004 Aug; 263(1-2):11-20. PubMed ID: 15524163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibody against beta1-adrenergic receptor and left ventricular remodeling changes in response to metoprolol treatment.
    Miao GB; Liu JC; Liu MB; Wu JL; Zhang G; Chang J; Zhang L
    Eur J Clin Invest; 2006 Sep; 36(9):614-20. PubMed ID: 16919043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bradycardic therapy improves left ventricular function and remodeling in dogs with coronary embolization-induced chronic heart failure.
    Cheng Y; George I; Yi GH; Reiken S; Gu A; Tao YK; Muraskin J; Qin S; He KL; Hay I; Yu K; Oz MC; Burkhoff D; Holmes J; Wang J
    J Pharmacol Exp Ther; 2007 May; 321(2):469-76. PubMed ID: 17277196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic blocking of beta 3-adrenoceptor ameliorates cardiac function in rat model of heart failure.
    Gan RT; Li WM; Xiu CH; Shen JX; Wang X; Wu S; Kong YH
    Chin Med J (Engl); 2007 Dec; 120(24):2250-5. PubMed ID: 18167212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of beta-blockers on beta3-adrenoceptor expression in chronic heart failure.
    Zhao Q; Wu TG; Jiang ZF; Chen GW; Lin Y; Wang LX
    Cardiovasc Drugs Ther; 2007 Apr; 21(2):85-90. PubMed ID: 17440824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of beta3-adrenoceptor antagonist on the cardiac function and expression of endothelial nitric oxide synthase in a rat model of heart failure].
    Gan RT; Li WM; Wang X; Wu S; Kong YH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Nov; 19(11):675-8. PubMed ID: 17996136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of peripheral chemoreceptors causes positive inotropic effects in a working heart-brainstem preparation of the rat.
    Braga VA; Zoccal DB; Soriano RN; Antunes VR; Paton JF; Machado BH; Nalivaiko E
    Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1156-9. PubMed ID: 17880370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic partial unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in failing rat hearts.
    Wang J; Tsukashita M; Nishina T; Marui A; Yoshikawa E; Muranaka H; Matsuoka S; Ikeda T
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):465-70. PubMed ID: 19185171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New concepts in post-infarction ventricular remodeling.
    Udelson JE; Patten RD; Konstam MA
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S3-12. PubMed ID: 14564229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin derivate improves left ventricular systolic performance and attenuates left ventricular remodeling in rats with myocardial infarct-induced heart failure.
    Xu K; George I; Klotz S; Hay I; Xydas S; Zhang G; Cerami A; Wang J
    J Cardiovasc Pharmacol; 2010 Nov; 56(5):506-12. PubMed ID: 20881614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective beta1-blockade attenuates post-infarct remodelling without improvement in myocardial energy metabolism and function in rats with heart failure.
    Omerovic E; Bollano E; Soussi B; Waagstein F
    Eur J Heart Fail; 2003 Dec; 5(6):725-32. PubMed ID: 14675850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The function of beta receptors in chronic left ventricular insufficiency].
    Cabanes L; Weber S; Guérin F
    Rev Prat; 1990 Oct; 40(23 Suppl):13-7. PubMed ID: 1980029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Β-adrenergic blockade combined with subcutaneous B-type natriuretic peptide: a promising approach to reduce ventricular arrhythmia in heart failure?
    Thireau J; Karam S; Roberge S; Roussel J; Aimond F; Cassan C; Gac A; Babuty D; Le Guennec JY; Lacampagne A; Fauconnier J; Richard S
    Heart; 2014 Jun; 100(11):833-41. PubMed ID: 24667281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of ventricular fibrillation requires central beta-adrenoceptor blockade in rabbits.
    Ablad B; Bjurö T; Björkman JA; Edström T
    Scand Cardiovasc J; 2007 Aug; 41(4):221-9. PubMed ID: 17680509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential beneficial effects of beta adrenergic blockade in the treatment of ventricular fibrillation.
    Bassiakou E; Xanthos T; Papadimitriou L
    Eur J Pharmacol; 2009 Aug; 616(1-3):1-6. PubMed ID: 19555681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic treatment with the new ultra-long-acting β2 -adrenoceptor agonist indacaterol alone or in combination with the β1 -adrenoceptor blocker metoprolol on cardiac remodelling.
    Rinaldi B; Donniacuo M; Sodano L; Gritti G; Martuscelli E; Orlandi A; Rafaniello C; Rossi F; Calzetta L; Capuano A; Matera MG
    Br J Pharmacol; 2015 Jul; 172(14):3627-37. PubMed ID: 25825265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.